Nothing Special   »   [go: up one dir, main page]

SE8307146L - 7-oxabicykloheptan-substituerade aminoprostaglandinanaloger - Google Patents

7-oxabicykloheptan-substituerade aminoprostaglandinanaloger

Info

Publication number
SE8307146L
SE8307146L SE8307146A SE8307146A SE8307146L SE 8307146 L SE8307146 L SE 8307146L SE 8307146 A SE8307146 A SE 8307146A SE 8307146 A SE8307146 A SE 8307146A SE 8307146 L SE8307146 L SE 8307146L
Authority
SE
Sweden
Prior art keywords
oxabicycloheptan
analogs
substituted
substituted aminoprostaglandin
aminoprostaglandin analogs
Prior art date
Application number
SE8307146A
Other languages
English (en)
Other versions
SE8307146D0 (sv
SE454697B (sv
Inventor
M F Haslanger
M Nakane
S E Hall
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of SE8307146D0 publication Critical patent/SE8307146D0/sv
Publication of SE8307146L publication Critical patent/SE8307146L/sv
Publication of SE454697B publication Critical patent/SE454697B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C247/00—Compounds containing azido groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/09—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by hydrolysis
    • C07C29/10—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by hydrolysis of ethers, including cyclic ethers, e.g. oxiranes
    • C07C29/103—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by hydrolysis of ethers, including cyclic ethers, e.g. oxiranes of cyclic ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/12—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/22—Radicals substituted by singly bound oxygen or sulfur atoms etherified

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE8307146A 1982-12-27 1983-12-23 7-oxabicykloheptan-substituerade aminoprostaglandinanaloger SE454697B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/453,849 US4456616A (en) 1982-12-27 1982-12-27 7-Oxabicycloheptane substituted amino prostaglandin analogs and their use in inhibiting platelet aggregation and bronchoconstriction

Publications (3)

Publication Number Publication Date
SE8307146D0 SE8307146D0 (sv) 1983-12-23
SE8307146L true SE8307146L (sv) 1984-06-28
SE454697B SE454697B (sv) 1988-05-24

Family

ID=23802327

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8307146A SE454697B (sv) 1982-12-27 1983-12-23 7-oxabicykloheptan-substituerade aminoprostaglandinanaloger

Country Status (17)

Country Link
US (1) US4456616A (sv)
JP (1) JPS59122491A (sv)
AU (1) AU558875B2 (sv)
BE (1) BE898524A (sv)
CA (1) CA1192567A (sv)
CH (1) CH658659A5 (sv)
DE (1) DE3346047A1 (sv)
DK (1) DK596583A (sv)
FR (1) FR2538390B1 (sv)
GB (1) GB2132199B (sv)
HU (1) HU190651B (sv)
IE (1) IE56484B1 (sv)
IT (1) IT1205309B (sv)
LU (1) LU85149A1 (sv)
NL (1) NL8304404A (sv)
SE (1) SE454697B (sv)
ZA (1) ZA839159B (sv)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4537981A (en) * 1981-11-09 1985-08-27 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane and 7-oxabicycloheptene compounds
US4526901A (en) * 1984-01-26 1985-07-02 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted oxamide prostaglandin analogs and their use in treating thrombolytic disease
US4533673A (en) * 1984-01-26 1985-08-06 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted enaminone prostaglandin analogs and their use in treatment of thrombolytic disease
US4542156A (en) * 1984-04-26 1985-09-17 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted prostaglandin alcohols and their use in the treatment of thrombolytic disease
US4550120A (en) * 1984-04-30 1985-10-29 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted ethers and their use in treating thrombolytic disease
US4607049A (en) * 1985-04-22 1986-08-19 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane substituted thio prostaglandin analogs useful in the treatment of thrombolytic disease
US4639461A (en) * 1985-10-28 1987-01-27 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane substituted keto-amide prostaglandin analogs useful in the treatment of thrombotic disease
NZ218115A (en) * 1985-11-18 1990-02-26 Shionogi & Co Bicyclic sulphonamides and pharmaceutical compositions
JP2984077B2 (ja) * 1990-04-19 1999-11-29 塩野義製薬株式会社 スルホニルアミノ置換ビシクロ環系ヒドロキサム酸誘導体
EP1554572B1 (en) 2001-07-25 2009-10-14 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
CA2789262C (en) 2005-04-28 2016-10-04 Proteus Digital Health, Inc. Pharma-informatics system
US7915316B2 (en) * 2005-08-22 2011-03-29 Allergan, Inc Sulfonamides
WO2008036682A2 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
EP2398500B1 (en) 2009-02-20 2019-03-13 2-BBB Medicines B.V. Glutathione-based drug delivery system
US8445002B2 (en) 2009-05-06 2013-05-21 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4143054A (en) * 1977-11-04 1979-03-06 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane- and 7-oxabicycloheptene compounds
US4187236A (en) * 1977-11-04 1980-02-05 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane compounds
US4220594A (en) * 1977-11-04 1980-09-02 E. R. Squibb & Sons, Inc. Hexa- and octahydro-4,7-epoxyisobenzofuran-1-ol and hexa- and octahydro-5,8-epoxy-1H-2-benzopyran-3-ol
US4254044A (en) * 1977-11-04 1981-03-03 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane- and 7-oxabicycloheptene compounds
US4239778A (en) * 1978-09-12 1980-12-16 The University Of Illinois Foundation Azaprostanoic acid analogs and their use as inhibitors of platelet aggregation
GB2092589B (en) * 1979-01-05 1983-06-08 Nat Res Dev Prostaglandins
US4228180A (en) * 1979-11-01 1980-10-14 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane and 7-oxabicycloheptene prostaglandin analogs
US4335537A (en) * 1979-11-28 1982-06-22 Plectrum Pty. Limited Toy aircraft
US4416896A (en) * 1982-05-17 1983-11-22 E. R. Squibb & Sons, Inc. 7-Oxabicyclopheptane substituted amino prostaglandin analogs useful in the treatment of thrombolytic disease

Also Published As

Publication number Publication date
GB2132199A (en) 1984-07-04
JPS59122491A (ja) 1984-07-14
FR2538390A1 (fr) 1984-06-29
CA1192567A (en) 1985-08-27
AU558875B2 (en) 1987-02-12
AU2239883A (en) 1984-07-05
US4456616A (en) 1984-06-26
SE8307146D0 (sv) 1983-12-23
CH658659A5 (fr) 1986-11-28
IT8324352A0 (it) 1983-12-23
GB8333192D0 (en) 1984-01-18
HU190651B (en) 1986-10-28
SE454697B (sv) 1988-05-24
NL8304404A (nl) 1984-07-16
LU85149A1 (fr) 1984-10-22
ZA839159B (en) 1984-07-25
FR2538390B1 (fr) 1986-10-03
IT1205309B (it) 1989-03-15
DE3346047A1 (de) 1984-06-28
BE898524A (fr) 1984-06-22
IE832998L (en) 1984-06-27
IE56484B1 (en) 1991-08-14
DK596583A (da) 1984-06-28
DK596583D0 (da) 1983-12-23
GB2132199B (en) 1986-03-26

Similar Documents

Publication Publication Date Title
DE3378470D1 (en) 7-oxabicycloheptane substituted amino prostaglandin analogs
IE822648L (en) 7-oxabicycloheptane and 7-oxabicycloheptene compounds.
SE8307146D0 (sv) 7-oxabicykloheptan-substituerade aminoprostaglandinanaloger
IT8222608A0 (it) Procedimento per l'espossidazione di composti olefinici.
ES525692A0 (es) Procedimiento para la obtencion de dihidropirimidinas
CA1262138C (en) PROSTAGLANDIN TETRAHYDROTHIENYL SUBSTITUTE ANALOGS
IE830607L (en) Imidazolylphenylpyridazinones
ES529223A0 (es) Un procedimiento de preparacion de imino-2-pirrolidinas.
ES2054650T3 (es) Fenilacetonitrilos basicamente substituidos, su obtencion y medicamentos que los contienen.
EP0150710A3 (en) 7-oxabicycloheptane prostaglandin analogs
CA1262912C (en) TETRAHYDROFURANYLIC SUBSTITUTION DERIVATIVES OF PROSTAGLANDIN ANALOGS
CA1268468C (en) PROSTAGLANDIN ANALOGS WITH SUBSTITUTE THIABICYCLOHEPTAN GROUP
EP0140307A3 (en) 7-oxabicycloheptane ethers
PH24207A (en) 2-acylamino-6-amino-4,5,6,7-tetrahydrobenzothiazoles
ES522897A0 (es) "procedimiento para la preparacion de n-(2-metoxietil)-noroximorfona".
ATE92070T1 (de) Azachromanderivate.
DE3463143D1 (en) 1-0-alkyl-3-amino-propan-1.2-diol-2-0-phospholipids, process for producing the same and pharmaceutical preparations containing the same
IT8220803A0 (it) Procedimento per la preparazione del 2,3-diidro-2,2-dimetilbenzofuran-7olo.
IT1191034B (it) Composto ad attivita' vasodilatatrice,antiaggregante e ipocolesterolemizzante,procedimento per la sua preparazione e composizione farmaceutiche relative
IT1150612B (it) Procedimento per la preparazione del 1',5,7-tridrossi-4'-metossiflavone-7-rutinoside (diosmina)
IT8368287A0 (it) Procedimento per la riconciatura di pellami
ES510759A0 (es) "procedimiento para la obtencion de n-(2-oxo-1-pirrolidinil)acetil piperazinas sustituidas".
ES2037116T3 (es) Procedimiento para la obtencion de bencilaminoarildihidropiridinlactonas.
ES511814A0 (es) "procedimiento de preparacion del n-(1-propil-2-pirrolidinilmetil)-2-metoxi-5-sulfamoil-benzamida".
ES2034017T3 (es) Procedimiento para la obtencion de 3-fenil-2-estril-pirrolidinas.

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8307146-4

Effective date: 19920704

Format of ref document f/p: F